European Cell Therapy Players TiGenix And Cellerix Join Forces For Critical Mass, Cash
This article was originally published in The Pink Sheet Daily
Executive Summary
Lacking critical mass individually, Belgium's TiGenix and Spain's Cellerix have joined forces, attracting €33 million in new investment.